Abstract
Hepatitis C virus (HCV) treatments have dramatically progressed from poorly tolerated, moderately successful interferon-based therapies to highly effective all-oral interferon-free regimens. While sustained virologic responses have significantly improved with fixed-dose combinations (FDC) of these direct-acting antivirals (DAA), cost remains high and certain populations of patients remain difficult to treat. Glecaprevir (GLE, an NS3/4A protease inhibitor) and pibrentasvir (PIB, NS5A inhibitor) were recently approved as a FDC therapy for HCV, and have expanded reach, reduced cost, and in certain populations, reduced HCV treatment duration. GLE/PIB is effective across all genotypes, and has been shown to be effective in HIV-infected patients, patients with chronic kidney disease, and Child-Pugh A-compensated cirrhosis. GLE/PIB is also effective for a shortened duration of 8 weeks in treatment-naive non-cirrhotic patients.
References
Jun 9, 2012·Journal of Viral Hepatitis·F Poordad, D Dieterich
Aug 2, 2013·Nature·Marcus DornerAlexander Ploss
Jul 30, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jane P MessinaEleanor Barnes
Jan 27, 2015·The Lancet Global Health·Mohga Kamal-Yanni
Feb 14, 2015·Expert Opinion on Pharmacotherapy·Radhika Kumari, Mindie H Nguyen
Nov 26, 2015·Annals of Internal Medicine·Anita KohliShyam Kottilil
Dec 24, 2015·Viruses·Asma Ahmed, Daniel J Felmlee
Feb 24, 2016·Expert Opinion on Pharmacotherapy·Elana S RosenthalMichael A Polis
Apr 27, 2016·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Lisa I BackusLarry A Mole
May 18, 2016·Infectious Agents and Cancer·Elana S Rosenthal, Camilla S Graham
Oct 28, 2016·Hepatology International·Sarah KattakuzhyShyam Kottilil
Sep 15, 2016·Hepatology International·Chandana PapudesuShashwatee Bagchi
Dec 9, 2016·Hepatology International·Rebecca LeeEleanor Wilson
Jan 28, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Fred PoordadFederico J Mensa
Apr 17, 2017·Journal of Hepatology·Paul Y KwoFederico J Mensa
Aug 3, 2017·World Journal of Gastroenterology : WJG·Nyan L LattAmandeep K Sahota
Aug 9, 2017·Annals of Internal Medicine·Sarah KattakuzhyUNKNOWN ASCEND Providers
Aug 15, 2017·The Lancet. Gastroenterology & Hepatology·Benjamin EmmanuelGeorge Lau
Aug 19, 2017·The Lancet Infectious Diseases·Xavier FornsFederico J Mensa
Sep 20, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·David WylesFederico J Mensa
Sep 21, 2017·Drugs·Yvette N Lamb
Sep 28, 2017·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Tarik AsselahFederico J Mensa
Oct 12, 2017·The New England Journal of Medicine·Edward GaneFederico J Mensa
Oct 21, 2017·Journal of Gastroenterology·Hiromitsu KumadaKazuaki Chayama
Nov 7, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Cameron SikaviSammy Saab
Nov 21, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Fred PoordadFederico J Mensa
Citations
Sep 18, 2018·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Nicholas WetterstenSaima Aslam
Nov 18, 2018·Current Drug Safety·Benedetto CaroleoLuca Gallelli
Jun 25, 2020·Revista Da Sociedade Brasileira De Medicina Tropical·Vinicius Lins FerreiraRoberto Pontarolo
Sep 22, 2018·Hepatology International·Ameer Abutaleb, Kenneth E Sherman
Sep 4, 2020·JAMA Network Open·Moosa TatarFernando A Wilson
Sep 21, 2019·The Annals of Pharmacotherapy·Jamie Huff, Rebecca Andersen
Oct 6, 2019·Arab Journal of Gastroenterology : the Official Publication of the Pan-Arab Association of Gastroenterology·Mortada El-Shabrawi, Fetouh Hassanin
Sep 13, 2020·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Alessio AghemoUNKNOWN MARS Study Group
Jun 26, 2021·Frontiers in Medicine·Zuqiang FuMing Yue
Oct 8, 2019·The Journal of Thoracic and Cardiovascular Surgery·Yasbanoo MoayediKiran K Khush